VEGF gene therapy eases pain, improves heart function
ANAHEIM, Calif., Nov. 12 – Injecting a growth factor gene directly into the heart is safe and appears highly effective in treating advanced coronary heart disease, two research teams report today at the American Heart Association’s Scientific Sessions 2001 conference. Both teams described follow-up results of experimental treatments in which each used a slightly different variation of the gene for vascular endothelial growth factor (VEGF). This naturally occurring protein plays a key role in initiating the growth of new blood vessels. One team reported two-year results with VEGF-1, the other reported a one-year follow-up with VEGF-2.
American Heart Association
Message posted by: Wouter Kalle
Bookmark and Share this page (what is this?)
Social bookmarking allows users to save and categorise a personal collection of bookmarks and share them with others. This is different to using your own browser bookmarks which are available using the menus within your web browser.
Use the links below to share this article on the social bookmarking site of your choice.
Read more about social bookmarking at Wikipedia - Social Bookmarking